• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 p16 诱导 mTORC1 介导的核苷酸代谢重编程。

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

机构信息

Department of Cellular & Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033, USA.

A.J. Drexel Autism Institute, Drexel University, Philadelphia, PA 19104, USA.

出版信息

Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. doi: 10.1016/j.celrep.2019.07.084.

DOI:10.1016/j.celrep.2019.07.084
PMID:31433975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6716532/
Abstract

Reprogrammed metabolism and cell cycle dysregulation are two cancer hallmarks. p16 is a cell cycle inhibitor and tumor suppressor that is upregulated during oncogene-induced senescence (OIS). Loss of p16 allows for uninhibited cell cycle progression, bypass of OIS, and tumorigenesis. Whether p16 loss affects pro-tumorigenic metabolism is unclear. We report that suppression of p16 plays a central role in reprogramming metabolism by increasing nucleotide synthesis. This occurs by activation of mTORC1 signaling, which directly mediates increased translation of the mRNA encoding ribose-5-phosphate isomerase A (RPIA), a pentose phosphate pathway enzyme. p16 loss correlates with activation of the mTORC1-RPIA axis in multiple cancer types. Suppression of RPIA inhibits proliferation only in p16-low cells by inducing senescence both in vitro and in vivo. These data reveal the molecular basis whereby p16 loss modulates pro-tumorigenic metabolism through mTORC1-mediated upregulation of nucleotide synthesis and reveals a metabolic vulnerability of p16-null cancer cells.

摘要

重新编程的代谢和细胞周期失调是两种癌症的特征。p16 是一种细胞周期抑制剂和肿瘤抑制因子,在癌基因诱导的衰老(OIS)期间上调。p16 的缺失允许细胞周期不受抑制地进展,绕过 OIS,并导致肿瘤发生。p16 的缺失是否会影响促肿瘤发生的代谢尚不清楚。我们报告称,通过增加核苷酸合成,p16 的抑制在重新编程代谢中起着核心作用。这是通过激活 mTORC1 信号转导来实现的,该信号转导直接介导编码核糖-5-磷酸异构酶 A(RPIA)的 mRNA 的翻译增加,RPIA 是戊糖磷酸途径中的一种酶。在多种癌症类型中,p16 的缺失与 mTORC1-RPIA 轴的激活相关。抑制 RPIA 仅在 p16 低表达的细胞中通过体外和体内诱导衰老来抑制增殖。这些数据揭示了 p16 缺失通过 mTORC1 介导的核苷酸合成上调来调节促肿瘤发生代谢的分子基础,并揭示了 p16 缺失的癌细胞在代谢上的脆弱性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/6163d5722fa5/nihms-1538192-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/c9c96d6042af/nihms-1538192-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/d78b3bbb0ad0/nihms-1538192-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/68e5a382a86a/nihms-1538192-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/6163d5722fa5/nihms-1538192-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/c9c96d6042af/nihms-1538192-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/d78b3bbb0ad0/nihms-1538192-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/68e5a382a86a/nihms-1538192-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176d/6716532/6163d5722fa5/nihms-1538192-f0005.jpg

相似文献

1
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.抑制 p16 诱导 mTORC1 介导的核苷酸代谢重编程。
Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. doi: 10.1016/j.celrep.2019.07.084.
2
Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer.《奔跑的光:核苷酸代谢驱动癌症中的衰老旁路》。
Trends Biochem Sci. 2019 Dec;44(12):991-993. doi: 10.1016/j.tibs.2019.10.007. Epub 2019 Nov 4.
3
MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.microRNA-124 通过靶向人结直肠癌细胞中的 PRPS1 和 RPIA mRNA 减少戊糖磷酸途径和增殖。
Gastroenterology. 2015 Nov;149(6):1587-1598.e11. doi: 10.1053/j.gastro.2015.07.050. Epub 2015 Aug 3.
4
Suppression of p16 alleviates the senescence-associated secretory phenotype.抑制 p16 可以减轻衰老相关的分泌表型。
Aging (Albany NY). 2021 Feb 6;13(3):3290-3312. doi: 10.18632/aging.202640.
5
Arginine methylation of ribose-5-phosphate isomerase A senses glucose to promote human colorectal cancer cell survival.核糖-5-磷酸异构酶 A 的精氨酸甲基化感知葡萄糖以促进人结直肠癌细胞存活。
Sci China Life Sci. 2020 Sep;63(9):1394-1405. doi: 10.1007/s11427-019-1562-y. Epub 2020 Mar 6.
6
Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.内皮细胞的复制性衰老可通过抑制 MTORC1 信号而延迟,其中涉及 MicroRNA-107。
Int J Biochem Cell Biol. 2018 Aug;101:64-73. doi: 10.1016/j.biocel.2018.05.016. Epub 2018 May 29.
7
Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer.核糖-5-磷酸异构酶 a 的抑制诱导活性氧诱导自噬、细胞凋亡和肺癌细胞衰老。
Int J Mol Sci. 2022 Jul 17;23(14):7883. doi: 10.3390/ijms23147883.
8
Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.5-磷酸核糖异构酶A通过PP2A和ERK信号通路调控肝癌发生。
Int J Cancer. 2015 Jul 1;137(1):104-15. doi: 10.1002/ijc.29361. Epub 2014 Dec 12.
9
Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain.鉴定出 5-磷酸核糖异构酶 A 的一种非经典功能,通过其新型 C 端结构域稳定并激活 β-连环蛋白,从而促进结直肠癌的形成。
PLoS Biol. 2018 Jan 16;16(1):e2003714. doi: 10.1371/journal.pbio.2003714. eCollection 2018 Jan.
10
The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate.免疫应答对 RNA 的反应通过限制核糖 5-磷酸来抑制核酸合成。
EMBO J. 2024 Jul;43(13):2636-2660. doi: 10.1038/s44318-024-00100-w. Epub 2024 May 22.

引用本文的文献

1
Peptide Drug: Design and Clinical Applications.肽类药物:设计与临床应用
MedComm (2020). 2025 Jul 25;6(8):e70287. doi: 10.1002/mco2.70287. eCollection 2025 Aug.
2
Molecular Regulation of SASP in Cellular Senescence: Therapeutic Implications and Translational Challenges.细胞衰老过程中衰老相关分泌表型(SASP)的分子调控:治疗意义与转化挑战
Cells. 2025 Jun 20;14(13):942. doi: 10.3390/cells14130942.
3
ATR promotes mTORC1 activity via de novo cholesterol synthesis.ATR通过从头合成胆固醇来促进mTORC1活性。
EMBO Rep. 2025 Jun 13. doi: 10.1038/s44319-025-00451-3.
4
KRAS-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC.KRAS驱动的磷酸戊糖途径重塑赋予了一种可靶向的脆弱性,与MRTX1133协同作用,可使胰腺导管腺癌实现持久缓解。
Cell Rep Med. 2025 Feb 18;6(2):101966. doi: 10.1016/j.xcrm.2025.101966.
5
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway.奥沙拉嗪通过STAT3/BCL-XL途径使透明细胞肾细胞癌对维托克拉克斯敏感。
Cancer Lett. 2025 Mar 31;613:217514. doi: 10.1016/j.canlet.2025.217514. Epub 2025 Jan 31.
6
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.磷酸戊糖途径:从机制到对胃肠道癌症的影响
Int J Mol Sci. 2025 Jan 13;26(2):610. doi: 10.3390/ijms26020610.
7
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.衰老、老化及年龄相关疾病中的代谢与代谢组学:多尺度视角
Front Med. 2025 Apr;19(2):200-225. doi: 10.1007/s11684-024-1116-0. Epub 2025 Jan 17.
8
Physiological and Pathological Role of mTOR Signaling in Astrocytes.mTOR信号通路在星形胶质细胞中的生理和病理作用
Neurochem Res. 2024 Dec 9;50(1):53. doi: 10.1007/s11064-024-04306-6.
9
Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production.醋酸盐通过 ACSS2 介导的乙酰辅酶 A 生成驱动卵巢癌细胞静止。
Mol Metab. 2024 Nov;89:102031. doi: 10.1016/j.molmet.2024.102031. Epub 2024 Sep 19.
10
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence.人类成纤维细胞衰老的系统转录组分析及时间建模
Front Aging. 2024 Aug 29;5:1448543. doi: 10.3389/fragi.2024.1448543. eCollection 2024.